Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C
Version of Record online: 8 SEP 2005
Journal of Gastroenterology and Hepatology
Volume 21, Issue 3, pages 575–580, March 2006
How to Cite
KOKOGLU, O. F., UÇMAK, H., HOSOGLU, S., CETINKAYA, A., KANTARCEKEN, B., BUYUKBESE, M. A. and ISIK, I. O. (2006), Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology, 21: 575–580. doi: 10.1111/j.1440-1746.2005.04008.x
- Issue online: 16 MAR 2006
- Version of Record online: 8 SEP 2005
- Accepted for publication 7 March 2005.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.